Curriculum vitae

PERSONAL INFORMATION

Name: Paridaens, Dion

WORK EXPERIENCE

2011-: Invited Professor, Department of Oculoplastic, Lacrimal & Orbital Surgery, Ophthalmology, Hopitaux Universitaires de Geneve (HUG), Geneve

1998-: Senior Consultant, Department of Oculoplastic Surgery, Rotterdam Eye Hospital, Rotterdam, The Netherlands

1996-1998: Junior staff member/fellow, Department of Oculoplastic Surgery, The Rotterdam Eye Hospital, Rotterdam, The Netherlands

EDUCATION AND TRAINING

1997: Visiting fellow to J. Rootman, MD, FRCSC, Professor Ophthalmology & Pathology, Department of Orbital Surgery, Vancouver Hospital, Vancouver, BC, Canada (May-July)

1996: Qualification and registration as “Ophthalmologist”

1994-1995: part-time worker at the Department of Forensic Medicine, Utrecht, The Netherlands

1993: Doctor of Philosophy (PhD) degree, University of Utrecht, Utrecht, The Netherlands

1992-1996: Residency in Ophthalmology, The F.C. Donders Institute of Ophthalmology, University Hospital of Utrecht, Utrecht, The Netherlands

1990-1992: Clinico-pathological fellowship on ocular tumours, Institute of Ophthalmology, Moorfields Eye Hospital, and St. Bartholomew’s Hospital, London, England

PERSONAL SKILLS AND COMPETENCIES

NATIVE LANGUAGE

Dutch

OTHER LANGUAGES

English (reading, writing, verbal: excellent
German (reading excellent, writing basic, verbal good)
French (reading good, writing basic, verbal basic)

SOCIAL SKILLS AND COMPETENCIES

Instructor of residents, Head of Oculoplastic & Orbital unit the Rotterdam Eye Hospital, Head of Oculoplastic & Orbital unit Geneva General Hospital, Director of Fellowship Programme the Rotterdam Eye Hospital, Involved in several Patient Advisory Groups, Member of a research Foundation. Organiser of several social events and symposia.

1998 – 2012: Member of the Dutch Ocular Oncology Committee (OOC)

1999 – 2012: Member of the Scientific Committee of the Rotterdam Eye Hospital

1997 – 2011 Editor-in-Chief of Orbit, the International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery

2011- Honorary Editor-in-Chief of Orbit and member of Editorial Board

2000-: Regular reviewer for international (peer-reviewed) ophthalmological journals (Ophthalmology, Br J Ophthalmol, Eye, Orbit, OPRS, Int J Ophthalmol)

2000-: Invited speaker at international Meetings and Meetings abroad (Germany, Colombia, Switserland, Spain, Italy, Austria, Belgium, Denmark, Serbia, Japan, India)

2000 – 2015 : Member of the Medical Advisory Board of the Dutch Thyroid Foundation (Schildklierstichting Nederland)

2000 – : Elected (full) Member of the European Society of Ophthalmic Plastic & Reconstructive Surgery (ESOPRS)

2001 – 2015: Member of the Medical Advisory Board of the Dutch Society Graves Patients (Nederlandse Vereniging voor Graves Patienten (NVGP)

2001-: Member of the Netherlands Advisory Committee of the International Congress of Ocular Oncology

2002: Visiting Oculoplastic and Orbital Surgeon, Zurich, Switserland (March)

2002-: Secretary of the S.W.O.O. Foundation (Eye Research), Rotterdam

2008-: Visiting Oculoplastic and Orbital Surgeon, University Hospital Catania, Sicily, Italy (June 2008, Oct 2009, Aug 2010)

2008 -: Honorary Consultant Oculoplastic & Orbital Surgeon, Department of Ophthalmology, Erasmus Medical Center, Rotterdam

2010: Co-promotor (supervisor) PhD Thesis Dr Isabel Bleyen, entitled “Perspectives on Ocular Adnexal Surgeries” & Co-promotor (supervisor) PhD Thesis Dr Hanneke Mensink, entitled “Tumor Heterogeneity in Uveal Melanomas”

2012: Co-promotor (supervisor) PhD Thesis Dr Leendert van Steensel, entitled “Graves’ ophthalmopathy: a comprehensive role for platelet-derived growth factors”

Co-promotor (supervisor) PhD Thesis Thomas van den Bosch, MD, entitled “Genetic prognostic factors and follow-up in uveal melanoma”

2012: Elected Committee Member of the European Society of Ophthalmic Plastic & Reconstructive Surgery (E.S.O.P.R.S.), representing the Netherlands

2014: 2nd Promotor (supervisor) PhD Thesis Anna Koopmans, MD, on genetics and uvea malignant melanoma

2014: Chairman Expertgroup “Zorglijn Oculoplastische Chirurgie” Oogzorgnetwerk, the Netherlands

2014: Secretary European Society of Ophthalmic Plastic & Reconstructive Surgery (E.S.O.P.R.S.), elected during full-members meeting at Budapest, September 2014 (until 2018)

ORGANIZATIONAL SKILLS AND COMPETENCIES

Coordination and administration of people, projects and budgets; at work, in voluntary work (for example culture and sports) and at home, etc. 2002-: Chairman of oculoplastic sessions at annual meetings (ESOPRS Meetings; Dutch Society of Ophthalmologists), The World Congress of Ophthalmology or symposia (The Rotterdam Oculoplastic Symposium, The 1st Zurich Oculoplastic Symposium, Annual Meeting of Serb ophthalmologists, Update on Eyes, The Dutch Orbital Society Meeting, The Geneva Oculoplastic Symposium)

2002-: Chief Coordinator of Oculoplastic Fellowship in the Rotterdam Eye Hospital. The following fellows were trained: Frank Goes (Belgium), Farhad Hafezi (Switserland), Olga Weijtens (Netherlands), Christian Decock (Belgium), Tine Herman (Belgium), Kathleen Leroux (Belgium), Stephen Palm (Curacao), Jerrel Pawiroredjo (Surinam), Isabel Bleyen (Belgium), Ingemarie Moesen (Belgium), Piet Noe (Belgium), Thibaut Devogelaere (Belgium), An-Sofie Lafaut (Belgium), Annelies Gillis (Belgium), Geertrui Cools (Belgium), Christine Eenhorst (Netherlands), Dyonne Hartong (Netherlands), Katrien Brouwer (Belgium), Christien Weenen (Netherlands), Clemence Vasserot-Merle (Switserland), Pegah Heidari (Germany), Roel Verschooten (Belgium), Helene Heule (Netherlands), Sigi van Grasdorff (Belgium), Ronald de Keizer (the Netherlands), Anina Rengifo Coolman (the Netherlands), Gwendolijn Vandekerckhove (Belgium)

2004-: “plaatsvervangend – opleider” (repl. Instructor of residents The Rotterdam Eye Hospital)

2006: Co-organiser of the 1st Zurich Oculoplastic Symposium, Zurich, 4th of March

2007: Co-organiser of “New Developments in Ophthalmology”, October 21-24, Curacao.

2007: Organisor of the 3rd Rotterdam Oculoplastic Symposium, 23+24 November, Rotterdam

2011: Co-organiser of “New Developments in Ophthalmology”, Curacao, Oct 17-20

Course-organiser “Orbital Surgery 2011”. Programme de l’enseignement continu. Hopitaux Universitaires de Geneve, Geneva, Switserland, Oct 6

2012: Founding member of Dutch Orbital Society

2012: Founding member of Rotterdam Thyroid Center

2012: Co-organiser Symposium “Perspective in Orbital Care”, Rotterdam, the Netherlands

2012 – : Elected Member of the Committee of E.S.O.P.R.S., representing the Netherlands

2013: Co-initiator for the development of an e-learning system for ophthalmology

2013: Co-organiser of the first Dutch Orbital Society Meeting, the Netherlands

2013: Organiser International Oculoplastic Symposium Geneva

2013: Educational committee member for modernisation of resident education in the Rotterdam Eye Hospital

2013: Initiator/developer of web-based e-learning modules for ophthalmologists and residents

2014: Co-organiser International Course “New Developments in Ophthalmology, Oct 11-14, Curacao

2015: Co-organiser 2nd Dutch Orbital Society (DOS) Symposium, Driebergen, Jan 31

2015: Organizer of Oculoplastic Course for anterior segment surgeons during ESCRS, Barcelona, Spain, Sept 6

2016: Organizer of ESOPRS’ Oculoplastic Symposium (invited) during World Ophthalmology Congress (WOC), Guadalajara, Mexico, Febr

 

TECHNICAL SKILLS AND COMPETENCIES

Oculoplastic & orbital surgical skills, developer of several new surgical techniques, computer skilled, various computer programmes.

ARTISTIC SKILLS AND COMPETENCIES

Piano player (single and in group), Designer of 5 new operative techniques reported in the literature.

OTHER SKILLS AND COMPETENCIES/HOBBIES

Father of 3 children, squash player, cyclist, likes travelling

SURGICAL EXPERIENCE

Since 1996 Dr Paridaens has performed the following surgical procedures:

Orbital surgery: approx. 120 per year

Lacrimal surgery: approx.. 300 per year

Oculoplastic surgery: approx. 720 per year

Orbital surgery: incisional/excisional biopsy, translid/transconjunctival orbitotomies, eye removal (evisceration, enucleation, exenteration), socket reconstruction (implants, dermofat grafts, mucosal grafts), orbital decompression (bony, fat), orbital fracture repair, removal of FBs

Lacrimal surgery: external/endo DCR, Jones tubes, dacryocystectomy, drainage abcess, stent placements, canalicular reconstruction, canalicular slicing, 3-snip, dacryocystoplasty, tumor excision

Oculoplastic surgery: ptosis repair (levator reinsertion, frontalis suspension (fascia lata, silicone rod), levator resection, Fasanella, Mullermuscle resection), eyelid reconstruction (simple and complex, various flaps and grafts), malposition procedures, gold weights, brow lifting (direct, indirect), excisional and incisional biopsies, trichiasis/distichiasis treatments, cryotherapy, blepharoplasty (upper and lower eyelids), midface lifting, levator desinsertion. Conjunctival resection and reconstruction with amniotic membrane or conjunctival or buccal autografts

COURSES “Contour tread lifting” (London, 2007), “Periocular Botulinum A injections for cosmetic indications” (Rotterdam, May 2014), Workshop injectables (Venray, February 2014; IJsselstein, June 2014).

“How to collaborate with difficult people” (workshop Rotterdam, October 2014)

PUBLICATIONS AND ABSTRACTS

Original Articles published or accepted in peer reviewed journals

1. Koopmans AE, Ober K, Dubbink HJ, Paridaens D, Naus NC, Belunek S, Krist B, Post E, Zwarthoff EC, de Klein A, Verdijk RM; Rotterdam Ocular Melanoma Study Group. Prevalence and implications of TERT Promoter Mutation in Uveal and Conjunctival Melanoma and in benign and premalignant conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci. 2014 Aug 26;55(9):6024-30

2. Bol KF, Mensink HW, Aarntzen EH, Schreibelt G, Keunen JE, Coulie PG, de Klein A, Punt CJ, Paridaens D, Figdor CG, de Vries IJ. Long overall survival after dentritic cell vaccination in metastatic uveal melanoma patients. Am J Ophthalmol 2014 Jul 17 (Epub ahead of print)

3. Heidari P, Verdijk RM, van den Bosch WA, Paridaens D. Biopsy-Proven Recurrence of Unilateral IgG4-Related Orbital Inflammation after 20 years. Orbit 2014 Jun 9:1-4 [Epub ahead of print]

4. Virakul S, Dalm VA, Paridaens D, van den Bosch WA, Hirankarn N, van Hagen PM,

Dik WA. The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation. Graefes Arch Clin Exp Ophthalmol. 2014 May 30. [Epub ahead of print]

5. Moesen I, van den Bosch WA, Wubbels R, Paridaens D. Is dry eye associated with acquired aponeurogenic blepharoptosis? Orbit 2014 Jun;33(3):173-7. Epub 2014 Mar 24

Impact factor: TBA HUG

6. Koopmans AE, Verdijk RM, Brouwer RW, van den Bosch TP, van den Berg MM, Vaarwater J, Kockx CE, Paridaens D, Naus NC, Nellist M, van Ijcken WF, Kilic E, de Klein A. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol 2014 Mar 14 Epub ahead of print

Impact factor: 5,3

7. van Beek JG, Koopmans AE, Vaarwater J, de Rooi JJ, Paridaens D, Naus NC, de Klein A, Verdijk RM, Kiliç E. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma. Invest Ophthalmol Vis Sci. 2014 Mar 4;55(3):1284-91.

Impact factor: 3,4

8. Verdijk RM, Heidari P, Verschooten R, van Daele PL, Simonsz HJ, Paridaens D. Raised numbers of IgG4-positive plasma cells are a common histopathological finding in orbital xanthogranulomatous disease. Orbit 2014 Feb;33(1):17-22. Epub 2013 Oct 21

Impact factor: TBA HUG

9. Koopmans AE, Vaarwater J, Paridaens D, Naus NC, Kilic E, de Klein A. Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11. Br J Cancer 2013 Jul 23;109(2):493-6. Epub 2013 Jun 18

Impact factor: 5.0

10. Verdijk RM, Koopmans AE, Kilic E, Paridaens D, de Klein A. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea. JAMA Ophthalmol. 2013 Jun 1;131(6):814-6

Impact factor: 3.7

11. Siban M, Weijtens O, van den Bosch W, Paridaens D. Efficacy of transconjunctival excision of orbital fat prolapse: a long-term follow-up study. Acta Ophthalmol 2013 Feb 13. doi: 10.1111/aos.12032. [Epub ahead of print] HUG Impact factor: 2,8

12. Bijlsma WR, Kalmann R, Dekkers J, Paridaens D, Mourits MP, Kloos R, de Groot-Mijnes JD. Identification of infectious entities in idiopathic orbital inflammation biopsies. Br J Ophthalmol. 2013 May;97(5):664-5. doi: 10.1136/bjophthalmol-2012-302926. Epub 2013 Feb 1 Impact factor: 2.9

13. Maaijwee K, Nowak PJ, van den Bosch WA, Paridaens D. Fractionated stereotactic radiotherapy for cavernous hemangiomas of the orbital apex. Acta Ophthalmol 2012 Dec;90(8):e655-7. doi: 10.1111/j.1755-3768.2012.02411.x. Epub 2012 Sep 13

Impact factor: 2,8 HUG

14. van Steensel L, Hooijkaas H, Paridaens D, van den Bosch WA, Kuijpers RW, Drexhage HA, van Hagen PM, Dik WA. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves’ ophthalmopathy patients. J Clin Endocrinol Metab. 2012 Jun;97(6):E944-53. doi: 10.1210/jc.2012-1020. Epub 2012 Mar 21. HUG Impactfactor: 6,5

15. van den Bosch T, van Beek J, Vaarwater J, Verdijk RM, Naus NC, Paridaens D, de Klein A, Kilic E. Higher percentage of FISH-determined monosomy 3 and 8q gain in uveal melanoma cells relate to poor prognosis and shorter desease free interval. Invest Opthalmol Vis Sci. 2012 May 14;53(6):2668-74. doi: 10.1167/iovs.11-8697 Impactfactor: 3,5 HUG

16. van Steensel L, Paridaens D, van Meurs M, van Hagen PM, van den Bosch WA, Kuijpers RW, Drexhage HA, Hooijkaas H, Dik WA. Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGH isoforms that orchestrate orbital fibroblast activation in Graves’ ophthalmopathy. J Clin Endocrinol Metab 2012 Mar; 97(3): E400-8.

Epub 2012 Jan 11

Impactfactor: 6,5

17. Muller K, Naus N, Nowak PJ, Schmitz PI, de Pan C, van Santen CA, Marijnissen JP, Paridaens DA, Levendag PC, Luyten GP. Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results, Radiother Oncol. 2012 Feb; 102(2): 219-24. Epub 2011 Aug 22

Impactfactor: 2,4

18. Vaarwater J, van den Bosch T, Mensink HW, van Kempen C, Verdijk RM, Naus NC, Paridaens D, Bruggenwirth HT, Kilic E, de Klein A. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Melanoma Res. 2012 Feb; 22(1):30-7

Impactfactor: 2,3 HUG

19. Verdijk RM, van den Bosch T, Naus NC, Paridaens D, Mooy CM, de Klein A. Histopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis of oncocytic uveal melanoma. Arch Ophthalmol 2011 Nov; 129(11):1501-2

Impactfactor: 3,5

20. Bleyen I, HIemstra CA, Devogelaere T, van den Bosch WA, Wubbels RJ, Paridaens D. Not only hard contact lens war but also soft contact lens wear may be associated with blepharoptosis. Can J Ophthalmol 2011 Aug; 46(4):333-6. Epub 2011 Jul 7

Impactfactor: 1,3

21. van Steensel L, van Hagen PM, Paridaens D, Kuijpers RW, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA. Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for graves’ophthalmopathy. Br J Ophthalmol 2011 May ;95(5):7325-8. Epub Feb 102011

Impactfactor: 2,9

22. Bijlsma WR, Paridaens D, Kalmann R. Treatment of severe idiopathic orbital inflammation with intravenous methylprednisolone. Br J Ophthalmol. 2011 Aug;95(8):1068-71. Epub 2011 Feb 24

Impactfactor: 2,9

23. Bijlsma WR, van den Bosch, van Daele PL, Paridaens D. Azathioprine and prednisone combination treatment for adult periocular and orbital xanthogranulomatous disease. Acta Ophthalmol. 2011 May; 89(3): 278-82. Epub 2009 Oct 30

Impactfactor: 2,8

24. Mensink HW, Vaarwater J, de Keizer RJ, de Wolff-Rouendaal D, Mooy CM, de Klein A, Paridaens D. Chromosomal aberrations in iris melanomas. Br J Ophthalmol 2011 Mar;95(3):424-8. Epub 2010 Sep 29 (*)

Impactfactor: 2,9

25. Bijlsma WR, Gils van C, Paridaens D, Mourists MP, Kalmann R. Risk factors for idiopathic orbital inflammation: a case-control study. Br J Ophthalmol. 2011 Mar;95(3):360-4. Epub 2010 Jul 31

Impactfactor: 2,9

26. Akdag F, van den Bosch WA, Ganteris E, Paridaens D. Sandwich block for eyelid reconstruction. Orbit. 2010 Apr;29(2):110-3

Impactfactor: TBA

27. Akdag F, Hafezi F, van den Bosch WA, Heule-Dieleman H, Tanghe H, Luyten GPM, Paridaens D. Clinical manifestations of orbital breast carcinoma metastasizing to the orbit. Ophtalmologe. 2010 Aug;107(8):728-32. German

Impactfactor: 0,9

28. van Sorge A, van den Bosch WA, Sotodeh M, Paridaens D. Exposure keratopathy following frontalis suspension with silicone sling in adults with severe neuro-myogenic ptosis. Acta Scand 2010 Mar 8 (Epub ahead of print)

Impactfactor: 2,8

29. van Steensel L, Paridaens D, Dingjan G, van Daele P, van Hagen P, Kuijpers R, van den Bosch W, Drexhage H, Hooijkaas H, Dik W. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbial fibroblasts in Graves’ Ophthalmopathy. Invest Ophthalmol Vis Sci. 2010 Feb:51(2):1002-7. 2009 Sep 24. (Epub ahead of print)

Impact factor: 3,5

30. Moesen I, Cleijnenbreugel H, Paridaens D. Corneal graft dehiscence during swinging eyelid orbital decompression. Ophthal Plast Recontr Surg. 2010 Jan-Feb; 26(1);54

Impactfactor: 0,6

31. Vijlbrief JW, Hafezi F, Paridaens D. Anterior surface breakdown following after evisceration: ‘classic’, ‘scleral modification’ and ‘scleral patch’ techniques. Ophthalmologe 2010;107:246-250. 2009 Jul 5. (Epub ahead of print)

Impactfactor: 0,9

32. Snaathorst J, Wewnaik A, Paridaens D, de Krijger RR, van der Meij EH. Primary epithelial tumors of the lacrimal gland; a retrospective analysis of 22 patients. Int J Oral Maxillofac Surg. 2009 Jul;38(7):751-7. 2009 Apr 13. (Epub ahead of print)

Impactfactor: 1,3

33. Steensel L van, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA. Imatinib mesylate and AMN107 are potential drugs for Craves ophthalmopathy by inhibition of PDGF-signaling in orbital fibroblasts. Invest Ophtalmol Vis Sci. 2009 Jul;5-(7):3091-8. Epub 2009 Feb 21.

Impactfactor: 3,5

34. Mensink HW, Vaarwater J, Kiliç E, Nous NC, Mooy N, Luyten G, Brüggenwirth HT, Paridaens D, de Klein A. Chromosome 3 intatumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci. 2009 Feb;50(2):500-. Epub 2008 Sep 29

Impactfactor: 3,5

35. Bleijen I, Paridaens D, Long-term follow-up of bicanalicular silicone intubation in acquired stenosis of the nasolacrimal duct. Bull Soc Belge Ophthalmol. 2008;(309-310):23-6

Impactfactor: TBA

36. Bleijen I, Faber de JT, Paridaens D. [Strabismus correction as an alternative treatment to evisceration and enucleation for artificial eye prosthesis intolerance in atrophic eyes] (Article in German) Ophthalmologe. 2008 Oct;105(10):946-8

Impactfactor: 0,9

37. van Gils W, Lodder EM, Mensink HW, Kiliç E, Naus NC, Brüggenwirth H, van IJcken W, Paridaens D, Luyten GP, de Klein A. Expression profiling in uveal melanoma provides a strong marker for survival an reveals two regions on chromosome 3p related to prognosis. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4254-62. Epub 2008 Jun 14

Impactfactor: 3,5

38. Paridaens D, van den Bosch WA, Orbicularis muscle advancement flap combined with free posterior and anterior lamellar grafts: a 1-stage sandwich technique for eyelid reconstruction. Ophthalmology 2008 Jan;115(1):189-94. Epub 2007 Jun 7.

Impactfactor: 5,0

39. Mensink HW, Kiliç E, Vaarwater J, Douben H, Paridaens D, de Klein A. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet. 2008 Mar;181(2):108-11

Impactfactor: 1,6

40. van Gils W, Kiliç E, Brüggenwirth HT, Vaarwater J, Verbiest MM, Beverloo B, van Tilburg ME, Paridaens D, Luyten GP, de Klein A. Regional deletion and amplification on chromosome 6 in an uveal melanoma case without abnormalities on chromosome 1p, 3 and 8. Melanoma Res. 2008 Feb ;18(1):10-5

Impactfactor: 2,3

41. Moesen I, Paridaens D. A tarsoconjunctival advancement flap combined with orbicularis muscle mobilization an a free skin graft: a technique for lower eyelid reconstruction. Br J Ophthalmol 2001;91:1695-97

Impactfactor: 2,9

42. van Gils W, Mensink HW, Kiliç E, Vaarwater J, Verbiest MM, Paridaens D, Luyten GP, de Klein A, Brüggenwirth HT. Expression of APITD1 Is Not Related to Copy Number Changes of Chromosomal Region 1p36 or the Prognosis of Uveal Melanoma. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4919-23

Impactfactor: 3,5

43. Bleyen I, van den Bosch WA, Bockholts D, Mulder P, Paridaens D. Silicone Intubation with or without Balloon Dacryocystoplasty in Acquired Partial Nasolacrimal Duct Obstruction. Am J Ophthalmol 2007 Nov;144(5):776-780. Epub 2007 Sep 17

Impactfactor: 4,3

44. Leroux K, den Bakker MA, Paridaens D. Acquired capillary hemangioma in the lacrimal sac region. Am J Ophthalmol 2006 Nov;142(5):873-5

Impactfactor: 4,3

45. Kiliç E, van Gils W, Lodder E, Berna Beverloo H, van Til ME, Mooy CM, Paridaens D, de Klein A, Luyten GPM. Clinical and Cytogenetic analyses in uveal melanoma. Invest Ophthalmol Vis Sci 2006;47(9):3703-3708

Impactfactor: 3,5

46. De Jong – Hesse Y, Paridaens DA. Korrektur von Unterlid-retraktion mittels eines porösen Polyethylen (Medpor) Unterlidimplantats (Correction of Lower Eyelid Retraction with a Porous Polyethylene (Medpor) Lower Eyelid Spacer). Klin Monatsbl Augenkd 2006;223:577-582

Impactfactor: 0,4

47. Sivak-Callcott JA, Rootman J, Rasmussen SL, Nugent RA, White VA, Paridaens D, Currie Z, Rose G, Clark B, McNab AA, Buffam FV, Neigel JM, Kazim M. Adult Xanthogranulomatous Disease of the Orbit and Ocular Adnexa: New immunohistochemical findings and Clinical Review. Br J Ophthalmol 2006 May;90(5):602-8

Impactfactor: 2,9

48. Donker DL, Paridaens D, Mooy CM, van den Bosch WA. Blepharoptosis and upper eyelid swelling due to lipogranulomatous inflammation caused by silicone oil. Am J Ophthalmol. 2005 Nov;140(5):934-6

Impactfactor: 4,3

49. Sotodey M, Paridaens D, Keunen J, Schooneveld M, Baarsma S. Parneoplastic vitelliform retinopathy associated with cutaneous or uveal melanoma and metastases. Klin Monatsbl Augenheilk 2005 Nov;222(11):910-914

Impactfactor: 0,4

50. van den Broek P, de Faber JT, Kliffen M, Paridaens ADA. Leiomyoma of the anterior orbit. Arch Ophthalmol 2005 Nov; 123(11):1614

Impactfactor: 3,5

51. Muller K, Nowak PJCM, de Pan C, Marijissen JP, Paridaens D, Levensdag P, Luyten GPM, Effectiveness of fractionated sterotactic radiotherapy for uveal melanoma. Int J Radiation Oncology Biol Phys 2005;63(1):116-122

Impactfactor: 4,5

52. Kiliç E, Naus N, Gils van W, Klaver C. van Til van M, Verbiest M, Stijnen T, Mooy C, Paridaens D, Berna Beverloo H, Luyten G, de Klein A. Concurrent loss of chromosomes 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 2005;46(7):2253-2257

Impactfactor: 3,5

53. Paridaens D, Lie A, Grootendorst RJ, van den Bosch WA, Efficacy and side effects of ‘swinging eyelid’orbital decompression in Graves’ ophthalmopathy. A proposal for standardized evaluation of diplopia. Eye 2005 Mar 4 (Epub ahead of print); print 2006 Feb;20(2):154-62

Impactfactor: 1,9

54. Paridaens ADA, van den Bosch WA, van der Loos Th, Krenning EJP, van Hagen M. Pilot study of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with moderate Graves’ ophthalmopathy. Eye November 2004, epub ahead of print (2005); print:2005 Dec;19(12);1286-9 (*)

Impactfactor:1,9

55. Bodei L, Hofland LJ, Ferone D, Mooy CM, Kros JM, Paridaens ADA, Baarsma SG, Ferdeghini M, Van Hagen MP, Krenning EP, Kwekkeboom DJ. In vivo and in vitro detection of dopamine d2 receptors in uveal melanomas. Cancer Biother Radiopharm 2003 Dec;18(6):895-902

Impactfactor: 1,9

56. Mooy CM, van den Born LI, Baarsma S, Paridaens DA, Kraaijenbrink T, Bergen A, Weber BH. Hereditary x-linked juvenile retinoschisis. A review of the role of Muller cells. Arch Ophthalmol 2002;120(7):979-84

Impactfactor: 3,5

57. Naus NC, van Drunen E, Slater R, Mooy CM, Paridaens DA, Luyten GPM, de Klein A. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescent in- situ hybridization. Clin Cancer Res 2002;8(2):534-9

Impactfactor: 7,3

58. Paridaens D, Beekhuis H, van den Bosch W, Remeyer L, Melles G. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol 2001;85:658-66

Impactfactor: 2,9

59. Naus NC, van Drunen E, de Klein A, Luyten GPM, Paridaens DA, Alers JC, Ksander BR, Beverloo H, Slater RM. Characterization of complex chromosomal abnormalities in uveal melanoma by Fluorescent In Situ Hybridization, Spectral Karyotyping and Comparative Genomic Hybridiazation. Genes Chrom Cancer 2001;30(3):267-273

Impactfactor: 4,0

60. Paridaens DA, Verhoeff K, Bouwens D, van den Bosch WA. Transconjunctival orbital decompression in Graves’ ophthalmopathy: lateral wall approach ab interno. Br J Ophthalmol 2000;84:775-781

Impactfactor: 2,9

61. Colen TP, Paridaens DA, Lemij HG, Mourits MPh, van den Bosch WA. Comparative artificial eye motility with acrylic and hydroxyapatite spherical enucleation implants. Ophthalmology, 2000;107:1889-1894

Impactfactor: 5,0

62. van Ruijven R, van den Bosch WA, Eijkelenboom W, Paridaens D. The effect of retrobulbar irradiation on exophthalmos, ductions and soft tissue signs in Graves’ophthalmopathy. A retrospective analysis of 90 cases. Eye 2000;14:761-764

Impactfactor: 1,9

63. Paridaens, D.; Hans, K.; van Buitenen, S.; et al. The incidence of diplopia following coronal and translid orbital decompression in Graves’ orbitopathy. Eye 1998;12: 800-5

Impact factor: 1,9

64. Barton K, Curling OM, Paridaens ADA, Hungerford JL, The role of cytology in the diagnosis of periocular basal cell carcinomas. Ophthalmic Plast Reconstr Surg 1996;12(3):190-95

Impactfactor: 0,6

65. Paridaens ADA, McCartney ACE, Minassian DC, Hungerford JL. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol 1994;78:520-528

Impactfactor: 2,9

66. Paridaens ADA, Minassian DC, McCartney ACE, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinico-pathological study of 26 cases. Br J Ophthalmol 1994;78:252-259

Impactfactor: 2,9

67. Ter Bruggen JP, van Meel GJ, Paridaens ADA, van Norren D, Tijssen CC. Foveal photopigment kinetics abnormality: an early sign in myotonic dystrophy? Br J Ophthalmol 1992;76:594-597

Impact factor: 2,9

68. Paridaens ADA, Seregard S, Minassian D, Hungerford JL, McCartney ACE. AgNOR counts in conjunctival malignant melanoma lack prognostic value. Br J Ophthalmol 1992;76:621-623

Impact factor: 2,9

69. Paridaens ADA, McCartney ACE, Hungerford JL. Multifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmento. Br J Ophthalmol 1992;76:163-165

Impact factor: 2,9

70. Paridaens ADA, McCartney ACE, Curling OM, Lyons CJ, Hungerford JL. Impression cytology of conjunctival melanosis and melanoma. Br J Ophthalmol 1992;76:198-201

Impact factor: 2,9

71. Paridaens ADA, Alsexander RA, Hungerford JL, McCartney ACE. Oestrogen receptors in conjunctival malignant melanoma: an immunocytochemical study using formaling-fixed paraffin sections. J Clin Pathol 1991;44:840-843

Impact factor: 2,5

72. Paridaens ADA, Deuble K, McCartney ACE. Spontaneous congenital non-pigmented epithelial cysts of the iris stroma. Br J Ophthalmol 1992;76:39-42

Impact factor: 2,9

73. Paridaens ADA, Lyons CJ, McCartney ACE, Hungerford JL. Familial aggressive iris nevi in childhood. Arch Ophthalmol 1991;109:1552-4

Impact factor: 3,5

Reviews published or accepted in peer reviewed journals

1. van den Bosch T, Kilic E, Paridaens D, de Klein A. Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract. 2010;2010:666360136. Epub 2010 Jun 6

Impact factor: TBA

2. Mensink HW, Paridaens D, de Klein A. Genetics of uveal melanoma. Expert Rev Ophthalmol 2009;4(6):607-616

Impact factor: TBA

3. Editorial published or accepted in peer reviewed journals

1. Paridaens D. Editorial. ‘Global Impact by Orbit, the ‘Purple Journal’, Orbit, 2009;28(6):319

Impact factor: TBA

2. Paridaens D. The orbit, the devil and the ageing check. Orbit 2007 Sep;26(3);145-6

Impact factor: TBA

3. Paridaens D. Nasolacrimal stents: critical re-appraisal. Editorial. Orbit 2006;25:73-74

Impact factor: TBA

4. Paridaens D. Editorial: 22nd Meeting of ESOPRS: the ‘Louvain Experience’. Orbit 2005;24:163-164

Impact factor: TBA

5. De Keijzer R, Paridaens ADA. Foreword to the special issue. Orbit 2003;22:75

Impact factor: TBA

6. Paridaens D. Back in Medline! Editorial. Orbit 2002;21-99-100

Impact factor: TBA

7. Mourits Mph, Paridaens D. Goodbye and hello. Editorial. Orbit 2000;19(1):237-239

Impact factor: TBA

4. Case reports published or accepted in peer reviewed journals

1. Heidari P, Verdijk R, van den Bosch WA, Paridaens D. Biopsy-proven recurrence of unilateral IgG4-related dacryoadenitis and scleritis after 20 years. In press, HUG

2. Pluijmers BI, Koudstaal MJ, Paridaens D, van der Wal KG. Blowout fracture in a 3-year old. Craniomaxillofac Trauma Reconstr. 2013 Jun;6(2):133-6. Epub 2013 Mar 8.

Impact factor: ?

3. Hafezi F, moesen I, Carels G, Mooy C, Paridaens D. [Waldenstrom’s macroglobulinaemia of the lacrimal gland in a patient with sarcoidosis]. Ophthalmologe. 2010;107(1):60-3

Impact factor: 0,9

4. Mensink HW, van Doorn PA, Paridaens D. Concurrent myopathy in patients with Graves’ orbitopathy. Orbit 2009;28)1):66-70

Impact factor: TBA

5. Lindstedt EW, Hafezi F, Veckeneer MA, Mooy CM, Paridaens D. [Orbital inflammation due to intraocular malignant melanoma] Klin Monatsbl Augenheilk. 2008;225(10):888-9

Impact factor: 0,4

6. Bleyen I, Hafezi F, de Faber JT, Paridaens D. [Strabismus correction as an alternative treatment to evisceration and enucleation for articficial ehe prosthesis intolerance in atrophic eyes.] Ophthalmologe 2008;105(10):946-8

Impact factor: 0.9

7. Naseem M, Donker DL, Paridaens D. Blepharoptosis as a sign of severe thyroid orbitopathy. Eye. 2008 Oct 31. [Epub ahead of print]

Impact factor: 1,9

8. Paarlberg JC, den Hollander JC, Hafezi F, Paridaens D. [Adenoid cystic carcinoma of the upper eyelid.][Article in German] Ophthalmologe 2007 Apr 20; [Epub ahead of print]

Impact factor: 0,9

9. Hafezi F, Paridaens D. [Unusual orbital trauma with diplopia][Article in German] Ophthalmologe. 2007 Feb;104(2):163-4

Impact factor: 0.9

10. Moesen I, Hafezi F, Paridaens D. [Corneal dellen secondary to conjunctival chemosis following transconjunctival orbital decompression] [Article in German] Klin Monatsbl Augenheilkd. 2007 Nov;224(11):856-7

Impact factor: 0,4

11. Paarlberg K, vd Bosch W, Paridaens D. Reconstruction following lidmargin-sparing subtotal excision of upper eyelid. Orbit 2007 Dec;26(4):319-21

Impact factor: TBA

12. Palm SE, Paridaens D. Posterior uveal metastases from medullary thyroid carcinoma. Retina 2007 Jan;27(1):115-6

Impact factor: 2,8

13. Reyniers R, Paridaens D. Spontaneous globe luxation and floppy eyelid syndrome in a patient with Hashimoto’s disease. Eye 2007 Feb;21(2):303-4. Epub 2006 Sep 22

Impact factor: 1,9

14. Hafezi F, Bockholts D, van den Bosch WA, Paridaens AD Giant mucocele of all paranasal sinuses with massive bilateral globe displacement (Riesen-Mukozele der Nasennebenhöhlen mit massiver bilateraler Bulbusverlagerung). Ophthalmologe 2005 Jul 2, Epub ahead of print; print: 2006 Apr;103(4):340-1

Impact factor: 0,9

15. Mensink HW, Paridaens D. Fronto-ethmoidal mucocele after coronal orbital decompression. Orbit 2006;25:129-131

Impact factor: TBA

16. Mensink H, Mooy N, Paridaens D. In-situ adenocarcinoma-ex-pleomorphic adenoma of the lacrimal gland. Clin Exp Ophthalmol 2005; 33(6): 669-671

Impact factor: TBA

17. Vd Vegte S, Baarsma GJ, Uroloog, Paridaens ADA. Presumed choroidal metastasis of glans penis melanoma. Retina 2005 Sep;25(6):788-789

Impact factor: 2,8

18. Sotodeh M, v Bosch W, Keunen J, Paridaens D. Metastatic choroidal melanoma to the ipsilateral orbit 7 years after enucleation. Eye 2005 Mar 11 (Epub ahead of print); print: 2006 Feb;20(2):268-9

Impact factor: 1,9

19. Noe P, Baarsma GS, Paridaens ADA. Optic nerve sheath meningeoma diagnosed after complicated retrobulbar anesthesia for cataract extraction. Bull Soc belge Ophtalmol 2004;293:1-4

Impact factor: TBA

20. Hiemstra C, Mooy C, Paridaens D. Periocular angiosarcoma. Eye 2004 Jul;18(7):738-9

Impact factor: 1,9

21. Goes FM, Knegt PP, Paridaens ADA. Nasal polyps herniating through lacrimal-nasal bony

ostium mimicking dacryocystocele: a rare cause of DCR failure. Orbit 2004;23(3):189-191

Impact factor: TBA

22. Weijtens O, Mooy N, Paridaens D. Horner’s syndrome as manifestation of Wegener’s granulomatosis. Eye. 2004 Aug;18(8):846-8

Impact factor: 1,9

23. Paridaens ADA, Ruyven R, Eijkenboom W, Mooy CM, Bosch vd WA. Stereo-tactic irradiation of biopsy-proven primary optic nerve sheath meningeoma. Br J Ophthalmol 2003;87:246-247

Impact factor: 2,9

24. Lie A, Mooy C, Bosch vd W, Paridaens D. Caruncle tumor as the first sign of metastatic lung carcinoma. Am J Ophthalmol 2002;134(3):438-9

Impact factor: 4,3

25. Paridaens D, Bosch vd W, Beekhuis H. Reply to electronic letter to the Editor, Br J Ophthalmol, January 2002

Impact factor: 2,9

26. Paridaens ADA, Bosch vd WA. Letter to the Editor in reaction to: Follow-up of transnasal orbital decompression in severe Graves’ ophthalmopathy by Michel O, Oberlander N Neugebauer P, et al. Ophthalmology 2001;108(12):2155

Impact factor: 5,0

27. Ruyven v R, Bosch vd WA, Paridaens D. Ptosis as presenting sign of metastatic skin melanoma. Eye 2001;15:790-1

Impact factor: 1,9

28. Paridaens D, Mooy CM. Apocrine sweat gland carcinoma. Letter to the Editor. Eye 2001:15:253-255

Impact factor: 1,9

29. Ruyven RLJ, Bosch van den WA, Eykenboom WMH, Paridaens ADA. Retrobulbaire bestraling bij Graves’orbitopathie. NOG Amsterdam, maart 1999. Neth J Med 143(42);2126

Impact factor: 1,8

30. Mooy CM, Naus NC, Klein de A, Bosch van den WA, Paridaens D. Orbital chondrosarcoma developing in a patient with Paget’s disease. Am J Ophthalmol 1999;127:619-621

Impact factor: 4,3

31. Paridaens ADA, Kirkness C, Garner A, Hungerford JL. Recurrent malignant melanoma of the corneal stroma: a case of ‘black cornea’. Br J Ophthalmol 1992;76:444-446

Impact factor: 2,9

32. Paridaens ADA, McCartney ACE, Lavelle RJ, Hungerford JL. Nasal and orbital recurrence of conjunctival melanoma 21 years after exenteration. Br J Ophthalmol 1992;76:369-371

Impact factor: 2,9

33. Paridaens, ADA, McCartney ACE, Hungerford JL. Pre-malignant melanosis of the conjunctiva and the cornea in xeroderma pigmentosum. Br J Ophthalmol 1992;76:120-122

Impact factor: 2,9

34. Paridaens D, Vreuls R. An unusual cause of headache in childhood: neurocysticercosis, a case report. Lesotho Med Assoc J 1989;2:11-13

Impact factor: nil

Articles and reviews published or accepted in non-peer reviewed journals

1. Paridaens D. Evisceratie technieken en het post-evisceratie socket syndroom. Nieuwsbrief MMOP, October 2006

2. Interview met Dion Paridaens. Schildklier Magazine, maart 2001, 6-9

3. Paridaens D. Reactie van Dr D. Paridaens. Graves Bulletin 2001 (maart) 16-18

4. Faber De JTHN, Grootendorst R, Paridaens D. Subconjunctival abscess as a complication of strabismus surgery. Tijdschr voor Orthoptie 2001;1:11-16

5. Paridaens D. Orbita-decompressie via de ‘swinging eyelid’ techniek. Schildklierkrant, Dec 1999

6. Paridaens D. Oogkas-decompressie via de ‘swinging-eyelid’ techniek: een elegante en efficiente operatie voor Graves’ ophthalmopathie. Graves Bulletin, Sept 1999

7. Paridaens ADA. Van 3-snip tot dotter. Huisartsen bulletin, 1997

Original articles, reviews, editorials, letters, submitted in peer reviewed journals

1. Lindstedt, van den Bosch WA, Keunen JEE, Luyten GPM, Paridaens D. Hemorrhage mimicking extrascleral extension of uveal malignant melanoma.

2. Santana N, Muller K, Bleeker JC, Naus NC, Stijnen T, Creutzberg CL, Paridaens D, Vandenbroucke JP, Luyten GPM. Brachytherapy versus Stereotactic Radiotherapy: What is best in Choroidal Melanomas?

3. Bol KF, Mensink HW, Aarntzen EHJG, Schreibelt G, Keunen JEE, Coulie PG, de Klein A, Punt CJA, Paridaens D, Figdor CG, de Vries IJM. Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients.

4. Hartong D, Eenhorst C, Hafezi F, Paridaens D. Limited tarsorrhaphy. HUG

Books/DVDs

1. Paridaens D, Hafezi F, van den Bosch WA. Oculoplastic Surgery: basic techniques. 3-DVD box, marketed in March 2009, accredited by the Dutch Society of Ophthalmology (N.O.G.) (ISBN: 978-90-79474-01-1)

2. Paridaens D. Ruimte voor Ogen. DVD (for patients with Graves’ orbitopathy, produced in collaboration with the Dutch Society for Graves Orbitopathy Patients)

3. Paridaens D, van den Bosch WA. Oculoplastic Surgery: Eyelid Reconstruction. 2-DVD box, accredited by the Dutch Society of Ophthalmology (N.O.G.) (ISBN: 978-90-79474-00-4)

Chapters

1. Experimental, functional and electrophysiological research into the effect of ORG. 2766 on partially denervated rat muscle tissue, Department of Molecular Biology, State University of Utrecht, published in part in thesis: Functional and electrophysiological evaluation of damaged peripheral nerve: neurotrophic actions of ORG.2766, by Paul de Koning, 1987

2. Paridaens ADA, Kacperek A, Broughton C, Parkins CS, McCartney ACE, Hungerford JL. Proton and Cobalt-60 irradiation of ocular and cutaneous melanoma cell-lines in vitro. In: thesis: Experimental and clinico-pathological aspects of ocular melanomas, Utrecht, The Netherlands. In: ‘Experimental and Clinico-pathological Aspects of Ocular Melanomas. (thesis) A.D.A. Paridaens, Utrecht, 1993, ISBN 90 393 0239 1, CIP details Royal Library, The Hague

3. Non-invasive intracranial pressure monitoring. A technique for reproducable fontanelle pressure measurements, Department of Neurology, University Hospital of Utrecht, published in part in thesis: Non-invasive intracranial pressure monitoring in infantile hydrocephalus, by P. Hanlo, 1995

4. Mooy CM, Luyten GPM, Paridaens ADA. Tumoren van de oogleden, ogen en orbita. Pg: 441-448. In: Oncologie (7e druk, 2005). Onder redactie van vdVelde, van Krieken, de Mulder en Vermorken. Bohn Stafleu van Loghum, Houten, the Netherlands

5. Paridaens D. In: Het Hoofd-Hals Formularium. 2007, Publ: Bohn Stafleu van Loghum.

6. Van Den Bosch Th, JVan Beek J, Kilic E, Naus N, Paridaens D and De Klein A. Melanoma / Book 3 (ISBN 978-953-307-575-4). Chapter title: Genetics of uveal melanoma

7. Mooy CM, Luyten GPM, Paridaens ADA. Tumoren van de oogleden, ogen en orbita. Pg: 557-565. In: Oncologie (8e druk, 2011). Onder redactie van vd Velde et al., Bohn Stafleu van Loghum, Houten, The Netherlands

 Thesis

(thesis accepted for the degree of Doctor of Philosophy at the University of Utrecht, The Netherlands)

‘Experimental and Clinico-pathological Aspects of Ocular Melanomas. A.D.A. Paridaens, Utrecht, 1993, ISBN 90 393 0239 1, CIP details Royal Library, The Hague.

Abstracts presented at international and national meetings

2014

1. Paridaens D. “Treatment of conjunctival neoplasia”. Symposium on Oculoplastic &Reconstructive Surgery, HUG, Geneva, Jan 16th

2. Paridaens D. “Brow lift or blepharoplasty”. Invited lecture. Symposium Update on Eyes, Seefeld, Austria, Febr 5-8

3. Paridaens D. “Eyelid tumours: state of the art surgery”. Invited lecture. Symposium Update on Eyes, Seefeld, Austria, Febr 5-8

4. Paridaens D. “Brow lift or blepharoplasty”. Oculoplastic Symposium HUG, Geneva, March 6

5. Van den Bosch Th en Paridaens D. “Seeding of irismelanoma following glaucoma surgery”. 208th Annual Meeting of Dutch Ophthalmic Society. Maastricht, March 26-28

6. Rengifo Coolman A, van den Bosch WA, de Waard P, Paridaens D. “Periocular complications of Baerveldt implants.”. 208th Annual Meeting of Dutch Ophthalmic Society. Maastricht, March 26-28

7. Littink KW, van ’t Hullenaar, Tjon Fo Sang M, Paridaens D, de Faber JTHN. Naevus of Ota complications: experience with 4 cases. 208th Annual Meeting of Dutch Ophthalmic Society. Maastricht, March 26-28

8. Koopmans, Paridaens D, de Klein A, et al. “SF3B1 and E1F1AX mutations in ocular melanoma with favorable prognostic profile.” 208th Annual Meeting of Dutch Ophthalmic Society. Maastricht, March 26-28

9. Kilic E, van Beek J, Paridaens D, et al. “Regression of ocular melanoma after fractionated stereotactic radiotherapy and the relationship with metastasis”. 208th Annual Meeting of Dutch Ophthalmic Society. Maastricht, March 26-28

10. Naus N, van Beek J, Paridaens D et al. “Fractionated SRT vs proton beam treatment in medium- and large uveal malignant melanomas”. 208th Annual Meeting of Dutch Ophthalmic Society. Maastricht, March 26-28

11. Mensink H, van den Bosch T, Paridaens D et al. “Update dendritic cell therapy as adjuvant therapy in high risk choroidal melanomas”. 208th Annual Meeting of Dutch Ophthalmic Society. Maastricht, March 26-28

12. Van Beek J, Naus N, Paridaens D et al. “Influence of treatment on the quality of life in uveal melanoma patients”. 208th Annual Meeting of Dutch Ophthalmic Society. March 26-28

13. Paridaens D and Mourits MPh. Modurators during Course by the Dutch Orbital Society. 208th Annual Meeting of Dutch Ophthalmic Society, Maastricht, March 26-28

14. Paridaens D. “Evisceration: state of the art”. Course on Eye Removal Techniques. 208th Annual Meeting of Dutch Ophthalmic Society, Maastricht, March 26-28

15. Paridaens D. “(Peri)ocular trauma due to fireworks in the Netherlands”. Symposium Vereniging Oog in Oog, Utrecht, April 5

16. Paridaens D. “Indications for surgery in the tearing patient”. Symposium on Lacrimal Surgery, Nijmegen, June 2014

17. Paridaens D. “Oculoplastische chirurgie: zorg op maat”. Oogzorgnetwerk symposium, Schiedam, September 2014

18. De Keizer R, Pinas D, van den Bosch WA, Paridaens D. Results of upper eyelid lengthening in Graves’ orbitopathy, ESOPRS Meeting Budapest, 13 September 2014

19. Paridaens D. “Eyelid malposition”. ESCRS Oculoplastic Course, Invited faculty. London, 14 September 2014

20. Paridaens D. “Lumps and bumps of the eyelids”. ESCRS Oculoplastic Course, Invited faculty. London, 14 September 2014

21. Paridaens D. “Controversies in the management of (pseudo)epiphora”. International Course “New Developments in Ophthalmology, Oct 11-14, 2014, Curacao

22. Paridaens D. “Multidisciplinary Treatment of Graves’ Orbitopathy”. International Course “New Developments in Ophthalmology, Oct 11-14, 2014, Curacao

 

2013

23. Paridaens D. “Oncologische bloopers”. 1st Dutch Orbital Society (DOS) Symposium, Driebergen, February 2

24. Van Etten PG, Zijlmans BLM, Wefers Bettink-Remeijer, Paridaens D. Orbitale refractieve chirurgie. 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

25. van Kinderen YB, Heidari P, Verdijk RM, van den Bosch WA, Paridaens D. Bioptie-bewezen recidief van unilateraal IgG4-gerelateerde dacryocystitis en scleritis na 20 jaar. 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

26. Kilic E, van Rij C, Veckeneer M, Paridaens D, Naus N. Chirurgische mogelijkheden bij complicaties na bestraling van uveamelanomen. 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

27. Mensink H, van den Bosch T, Bol K, Paridaens D et al. Dendritische celtherapie als adjuvante behandeling bij hoog risico choroidea melanomen. 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

28. Paridaens D, Heidari P, Verschooten R, van Daele P, Simonsz H, van den Bosch WA, Verdijk R. Zijn orbitale xanthogranulomen IgG4-gerelateerd? 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

29. Van den Bosch WA, Siban M, Weijtens O, Paridaens D. Lange termijn resultaten van transconjunctivale excisie van orbitale subconjunctivale vetprolaps. 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

30. De Keizer ROB, Pinas DS, Weijtens O, van den Bosch WA, Paridaens D. Factoren die de uitkomst beinvloeden van levator desinsertie chirurgie bij Graves’ orbitopathie. 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

31. Weijtens O, van den Heuvel B, van den Bosch WA, Paridaens D. Perioperatief antistollingsbeleid bij oculoplastische chirurgie. 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

32. Eenhorst C, Joshi N, Olver J, Paridaens D, van den Bosch WA. Laterale tarsale strip, laterale blokexcisie of laterale canthopexie? 207th Annual Meeting of Dutch Ophthalmic Society. March 20-23

33. Paridaens D. The anopthalmic socket. Lecture for residents and junior staff Department of Ophthalmology, HUG, Geneva, April 18

34. Paridaens D. Eyelid Reconstruction. Basic Principles of Eyelid Surgery, invited speaker, 2013 SOE Meeting, Copenhagen. June 9

35. Paridaens D. Wat bedreigt het oog? Invited lecture for Dutch residents in maxillofacial surgery, Nieuwegein, June 14

36. Paridaens D. “Ooglidmaligniteiten” and “Inflammatory and Infectious Disorders of the Orbit”. Invited lectures for Dutch residents in ophthalmology. Utrecht, June 15

37. Paridaens D. “Graves’ orbitopathy, an update”. Invited lecture. SOG Meeting, Locarno, Switzerland, August 30

38. Paridaens D. “Identification and treatment of cicatricial ectropion”. Invited faculty. Pre-Meeting Course in Orbital, Lacrimal and Ophthalmic Plastic Surgery, E.S.O.P.R.S Meeting, Barcelona, September 19th

39. Paridaens D. “Lumps and bumps of the eyelids”. Oculoplastic & Orbital Symposium, Geneva, Sept 26th

40. Paridaens D. “Ptosis surgery: tips, tricks and pitfalls”. Oculoplastic & Orbital Symposium, Geneva, Sept 26th

41. Paridaens D. “Lumps and bumps of the eyelids”. Invited lecture. E.S.C.R.S. Meeting, Amsterdam, Oct 6th

42. Paridaens D. “Ooglidtrauma”. Invited lecture. Evening symposium on Periocular Trauma. Dept of Maxillofacial Surgery, Erasmus Medical Center, Rotterdam, Oct 9th

43. Paridaens D. “Identification and treatment of cicatricial ectropion”. Refereeravond, The Rotterdam Eye Hospital, Rotterdam, Oct 15th

44. Paridaens D. “Graves Ophthalmopathy, unusual presentations”. Thyroid diseases: an update for clinical practice. Co-organiser, as part of the Rotterdam Thyroid Center, De Kuip, Rotterdam, Nov 5th.

45. Paridaens D. “Treatment of conjunctival neoplasia”. Invited lecture. Munich International Symposium on Ophthalmic Plastic and Reconstructive Surgery in conjunction with the XIV Beyer-Machule Course for Ophthalmic Plastic & Reconstructive Eyelid Surgery, Munich, November 29

46. Paridaens D. “Ectropium & Facial Palsy”. Invited lecture. Munich International Symposium on Ophthalmic Plastic and Reconstructive Surgery in conjunction with the XIV Beyer-Machule Course for Ophthalmic Plastic & Reconstructive Eyelid Surgery, Munich, November 28

47. Paridaens D. “Identification and treatment of periocular xanthogranuloma”. Invited lecture. 1st Annual Meeting of the Japanese Society of Ophthalmic Plastic and Reconstructive Surgery. Nagoya, Japan, December 15th

 

2012

48. Lushchyck T, Verdijk R, Weijtens O, van den Bosch W, Paridaens D. Diagnostiek en behandeling van carunkel tumoren. Retrospectieve case series. Annual Meeting of the Dutch Ophthalmic Society, 28-30 March 2012, Groningen

49. van Kinderen Y, Paridaens D. Alkaptonurie met progressief astigmatisme. Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Groningen

50. “Oncology 2011: an update”. Invited lecture. 4th Annual Symposium Ophthalmology: 12 maanden in vogelvlucht. January 13, 2012

51. “Eyelid surgery in facial palsy”. Oculoplastic seminar. Hopitaux Universitaires de Geneve, Switserland, Febr 9

“Entropion surgery” Oculoplastic seminar. Hopitaux Universitaires de Geneve, Switserland, Febr 9

52. “New developments in the treatment of Graves’ Orbitopathy”. Erasmus MC Immunology Mini-symposium Clinical and immunopathobiological aspects of Graves’ disease. March 7

53. de Keizer ROB, van Steensel L, van Hagen MP, Paridaens D, Kuijpers RWAM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA. Kweekmodel met volledig orbitaal weefsel identificeert Imatinib mesilaat en adalimumab als potentiele therapie voor Graves orbitopathie. Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Groningen

54. Weenen C, van den Bosch W, Weijtens O, Paridaens D. Mediale canthale reconstructie met vrije huidtransplantaten. Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Groningen

55. Soebhag RK, Weijtens O, Paridaens ADA. Een nieuwe techniek voor het sluiten van een ooglidranddefect na pentagonal blokexcisie. Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Groningen

56. Weijtens O, van den Heuvel B, van den Bosch WA, Paridaens ADA. Ooglidchirurgie onder plaatjes-agregatieremmers. Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Groningen.

57. Paridaens D. Orbita decompressie bij Graves orbitopathie. ‘Perspectives in Orbital Care’, symposium for ophthalmologists and maxillofacial surgeons, Rotterdam, May 25

58. Paridaens D. Orbitale inflammatoire aandoeningen. Eilanddagen, Schiermonnikoog, July 21-23

59. Paridaens D. “Entropion” and “Levator Resection”. Video-teaching. ESOPRS pre-meeting course. Tallinn, Estland. September 13 2012

60. Paridaens D. “Swinging Eyelid Orbital Decompression”. Keynote Lecture, 31st ESOPRS Annual Meeting, Tallinn, Estland, September 14 2012

61. Paridaens D. “What to do with lumps and bumps around the eye?” Oculoplastic Surgery for cataract & refractive surgeons Course. Invited speaker. ESCRS Meeting, Milan, September 9.

62. Paridaens D. “Grenzen van de oculoplastische chirurgie”. Invited speaker. 20 year anniversary Focuskliniek Rotterdam, September 10

63. Paridaens D. Oculoplastic Seminar: Adult ptosis surgery and upper eyelid blepharoplasty. H.U.G., Geneva, September 27 2012

64. Paridaens D. Lacerations des paupieres et voies lacrymales. Symposium “Traumatismes Oculaires”, H.U.G., Geneva, November 8

65. Paridaens D. Traanklachten en ptosis bij jonge kinderen. Seminar Oog voor het kind. November 30

 

2011

66. Oosterhof B, Creten O, de Faber JTHN, Paridaens ADA. Na val op stuur een bulbusfractuur ? Annual Meeting of the Dutch Ophthalmic Society, 31 March-02 April 2011, Maastricht

67. Van Luijk CM, Paridaens ADA. Orbitale metastase van neuro-endocriene tumor. Annual Meeting of the Dutch Ophthalmic Society, 31 March-02 April, Maastricht

68. Maaijwee KJM, van den Bosch WA, Paridaens D. Stereotactische radiotherapie voor caverneus hemangioom in orbita. Annual Meeting of the Dutch Ophthalmic Society, 31 March-02 April, Maastricht

69. Van Kinderen YB, Eenhorst C, Paridaens D, van den Bosch WA, Weijtens O. Ptosis bij unilaterale atrofie van alle extraoculaire spieren eci. Annual Meeting of the Dutch Ophthalmic Society, 31 March-02 April, Maastricht

70. De Keizer ROB, van Steensel L, van Hagen MP, Paridaens D, et al. Whole orbital tisssue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves’ orbitopathy. 30th Meeting of E.S.O.P.R.S. September 15-17, 2011

71. van den Bosch T, Vaarwater J, Mensink H, Kilic E, Paridaens D, de Klein A. Chromosoom 6q verlies en PARK2-gen in uveamelanomen. Annual Meeting of the Dutch Ophthalmic Society, 31 March-02 April, Maastricht

72. Bijlsma W, Paridaens D, Kalmann R. Treatment of idiopathic orbital inflammation with intravenous methylprednisolone. Annual Meeting of the Dutch Ophthalmic Society, 31 March-02 April, Maastricht

73. Hartong DT, Eenhorst CAE, Paridaens ADA. Gelimiteerde tarsorraphie : indicaties en techniek.

74. Eenhorst CAE, Hartong DA, Paridaens ADA, Weijtens O, van den Bosch WA. Crawford versus Ritleng siliconenintubatie bij congenitale epiphora.

75. “Approcio chirurgico desse anomalie di deflusso: dacriocistorinostomia ab externo”. Aggiornamenti di Chirurgia Oftalmoplastica. Azienda Ospedaliera “Cannizzaro”, Catania, Sicily, June 18. Invited Lecture

76. “Traumatologia palpebrale: approcio chirurgico”. Aggiornamenti di Chirurgia Oftalmoplastica. Azienda Ospedaliera “Cannizzaro”, Catania, Sicily, June 18. Invited Lecture

77. “Mullerectomie tarsoconjunctivale (TCM) vs reinsertion anterieure du m releveur palpebral (ALR) dans une blepharoptose aponeurotique”. 104 Jahrescongres Schweizerische Ophthalmologische Gesellschaft, Sept 2, Interlaken

78. “Blepharoptose et oeil sec”. 104 Jahrescongres Schweizerische Ophthalmologische Gesellschaft, Sept 2, Interlaken

79. “Orbital Decompression: the Inferomedial Perspective”. Invited Lecture. Teaching Course, 30th Meeting of E.S.O.P.R.S., September 15-17, 2011.

80. Cools G, van den Bosch WA, Hoevenaars N, Wubbels R, Paridaens D. A case control study comparing anterior levator-reinsertion with tarsoconjunctivo-mullerectomy for the correction of aponeurogenic blepharoptosis. 30th Meeting of E.S.O.P.R.S., September 15-17, 2011.

81. “Evisceration versus enucleation for painful eyes without tumour”. Invited Lecture for Association of European Ocularists (AEO), the Hague, Sept 30.

82. “Orbital decompression surgery for Graves’ orbitopathy (M. Basedow). Minisymposium Oculoplastic & Orbital Surgery. Programme de l’enseignement continu. HUG, Geneva, Oct 6

83. “Eye Removal: Cosmesis and Comfort”. Minisymposium Oculoplastic & Orbital Surgery. Programme de l’enseignement continu. HUG, Geneva, Oct 6

84. “Enucleation or evisceration?” New Developments in Ophthalmology, Curacao, Oct 18

85. “Management of eyelid laceration”. New Developments in Ophthalmology, Curacao, Oct 18

86. “New developments in lower eyelid blepharoplasty”. New Developments in Ophthalmology, Curacao, Oct 20

87. “New insights in the treatment of Graves’ orbitopathy”. Symposium Thyroid Diseases: an update for the clinical practice”. Rotterdam, November 10

88. “Orbital decompression surgery for endocrine orbitopathy”. Invited speaker. Journee des Ophtalmologues Romands. Chavannes-de-Bogis, Switserland, Nov 17

89. “Modern principles in reconstructive eyelid surgery”, invited speaker. Journee des Ophtalmologues Romands. Chavannes-de-Bogis, Switserland, Nov 17

 

2010

90. Gans D, Mooy N, Paridaens ADA. Een baby met 3 lenzen. 204th Annual Meeting of the Dutch Ophthalmic Society, 25-27 March, Maastricht

91. “Oculoplastische Chirurgie: an update”. Oogheelkunde 2010 symposium “12 maanden in vogelvlucht”. Amersfoort, 8 januari 2010

92. “Evisceration: the treatment of choice in the management of painful blind eyes without evidence of intraocular tumor”. Invited lecture (debate vs C. Hintschich). 1st World Congress on Controversies in Ophthalmologhy. Prague, Czech Republic, March 4-7, 2010

93. “Silicone intubation: the treatment of choice for children with epiphora after failed probing”. Invited lecture (debate vs G. Rose). 1st World Congress on Controversies in Ophthalmology. Prague, Czech Republic, March 4-7, 2010

94. “Hangende oogleden” Invited lecture for Update on Eyes, meeting of Dutch Ophthalmologists, Seefeld, Austria, March 10-13

95. ‘Eyelid malignancies involving the orbit’. Lecture in oculoplastic course for Dutch Ophthalmologists during 204th Meeting of Dutch Society of Ophthalmologists, March 25-27, Maastricht

96. “Eyelid reconstruction: the toolbox approach”. Invited lecture. XI Kongres Oftalmologa Srbije. September 22-25, Subotica, Serbia.

97. “Blepharoplasty”. 4th Rotterdam Oculoplastic Symposium, Rotterdam. November 20. Organiser and faculty

98. “Eyelid trauma”. Annual Meeting of Belgian Ophthalmologists (Adademica Ophthalmologica Belgica, OB 2010), Brussels. Nov 24-26. Invited lecture

99. “Advances in Periocular Surgery”. Welcome Symposium for Farhad Hafezi, MD PhD, Professor & Chairman of the HUG Ophthalmology Service, Geneva, Dec 2. Invited lecture

 

2009

100. van den Bosch WA, van den Bosch Th, Paridaens D. Phacomatosis pigmentovascularis. 203rd Annual Meeting of the Dutch Ophthalmic Society, 25-27 March, Groningen and : 2009 ESOPRS Meeting Marseille.

101. Reyniers R, Paridaens D. Ooglidretractie veroorzaakt door een fistel vanuit een sinus frontalis mucokele. 203rd Annual Meeting of the Dutch Ophthalmic Society, 25-27 March 2009, Groningen

102. Kesting S, Paridaens D. Een donkere zwelling aan de binnenzijde bovenooglid : quid ? 203rd Annual Meeting of the Dutch Ophthalmic Society, 25-27 March, Groningen

103. Weenen C, van den Bosch WA, Weijtens O, Paridaens D. HNPCC en plaveiselcelcarcinoom, Muir-Torre syndroom ? 203rd Annual Meeting of the Dutch Ophthalmic Society, 25-27 March, Groningen, and : 2009 ESOPRS Meeting Marseille.

104. De Keizer R, Ganteris-Gerritsen E, van den Bosch W, Paridaens D. Eyelid Reconstruction using Sandwich Block. 2009 ESOPRS Meeting Marseille.

105. Oculoplastic, Lacrimal & Orbital Surgery: what happened in 2008? Update course for Dutch Ophthalmologists. (Jaarsymposium Oogheelkunde 2009), Amersfoort, January 2009

106. ‘How to avoid complications in eye removal’. Lecture for patient organisation MMOP, Utrecht, the Netherlands, April 2009

107. ‘Eyelid malignancies involving the orbit’ Invited lecture for S.O.E. Meeting in Amsterdam, June 2009

108. ‘Infectious and Inflammatory Disorders of the Orbit’. L.V.A.O. Meeting, Utrecht, June 2009

109. ‘Management of Graves’ orbitopathy’. Thyroid Disease: an update for the clinical practice. 1st Thyroid Workshop. Regus World Port Center Rotterdam, September 1 2009

110. ‘The management of penetrating eyelid injury” Boerhave course Eye- & Orbitatraumatology, LUMC, Leiden, September 2009

111. ‘Upper lid blepharoplasty’ and ‘Lower lid blepharoplasty’. Invited lectures at oculoplastic symposium, University Hospital, Catania, Sicily, Italy, October 2009

112. “De oogziekte van Graves”. Invited lecture for the 21st Symposium Oogheelkundige Zorg. Free University Amsterdam, November 10, 2009

 

2008

113. Kilic E, Kempen van C, Mensink HW, Naus NC, Paridaens D, Mooy CM, Luyten GPM, Klein de A. Chromosomale veranderingen in familiaire oogmelanomen. 202nd Annual Meeting of the Dutch Ophthalmic Society, 2-4 April 2008, Maastricht

114. Mensink HW, Vaarwater J, Luyten GPM, Klein de A, Paridaens D. Heterogeniteit in choroidea melanomen. 202nd Annual Meeting of the Dutch Ophthalmic Society, 2-4 April, Maastricht

115. Lie AM, Missotten T, Paridaens ADA. Benigne Lymphoide Hyperplasie van de Chorioidea. 202nd Annual Meeting of the Dutch Ophthalmic Society, 2-4 April, Maastricht

116. Paridaens D, Moesen I. Waldenstrom’s macroglobulinémie van de traanklier bij een patiente met sarcoïdose. 202nd Annual Meeting of the Dutch Ophthalmic Society, 2-4 April, Maastricht

117. Paridaens D, Moesen I, Bosch van den WA, Wubbels R, Eijkenmans M. Blepharoptosis en keratoconjunctivitis sicca. 202nd Annual Meeting of the Dutch Ophthalmic Society, 2-4 April, Maastricht

118. Kuiper EJ, Noe P, Paridaens D. Fasanella-Servat procédure bij aponeurogene ptosis : werkt het ? 202nd Annual Meeting of the Dutch Ophthalmic Society, 2-4 April, Maastricht

119. ‘Graves’ orbitopathy, Disease Activity and Severity’. Immunology Meeting, The Rotterdam Eye Hospital, Rotterdam, Jan 15, 2008

120. Van Kempen C, Mensink HW, van Gils W, Paridaens D et al. Expression profiling in uveal melanoma provides a strong marker of patient survival, CELLULAR ONCOLOGY Volume: 30 Issue: 3 Pages: 261-261 Published: 2008

121. ‘20 years Swinging Eyelid Orbital Decompression in the Netherlands’. SOE guest lecture 202nd Annual Meeting of the Dutch Ophthalmic Society, March, Maastricht

122. ‘Surgical Treatment of Upper Eyelid Retraction’ and ‘Surgical treatment of Congenital Ptosis’. Invited lectures, University Hospital, Catania, Sicily, Italy, June 2008

 

2007

123. Paridaens D, Bleyen I, de Faber J. Strabismus correctie als alternatieve behandeling voor prothese intolerantie. 201st Annual Meeting of the Dutch Ophthalmic Society, 28-30 March 2007, Rotterdam

124. Lindstedt EW, Keunen JE, Luyten GP, Paridaens ADA. Epibulbaire lesie simuleert extraoculaire extensie uveamelanoom. 201st Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Rotterdam

125. Ganteris E, van den Bosch WA, Paridaens D. Ooglid reconstructie door middel van een ‘sandwich block’. 201st Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Rotterdam

126. Reyniers R, Paridaens D. Spontane subluxatie van de bulbus en floppy eyelid syndrome bij een patiënt met de ziekte van Hashimoto. 201st Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Rotterdam ‘Uitwendige chirurgische behandeling traanwegstenosen’ Boerhave cursus, Jan 26 (on invitation)

127. Mensink H, Vaarwater J, de Klein A, Hooijkaas H, Paridaens D, Luijten GPM. Osteopontin als serummarker in uvea melanomen. 201st Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Rotterdam

128. Naus NC, Muller K, Levendag P, Paridaens ADA, Luyten GPM. Folluw-up van oogmelanoom patiënten na stereotactische radiotherapie. 201st Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Rotterdam

129. Vijlbrief JWC, van den Bosch W, Paridaens D. Post evisceratie socket syndroom : voorstel voor een PESS score. 201st Annual Meeting of the Dutch Ophthalmic Society, 28-30 March, Rotterdam

130. ‘Periocular Melanoma’ Invited lecture. 11th World Congress on Cancers of the Skin (WCCS), Amsterdam, June 10th

131. ’Periocular Melanoma’. New Developments in Ophthalmology Symposium, International Course, Curacao, Netherlands Antilles, October 21-24, 2007

132. “Swinging Eyelid Orbital Decompression for Patients with Graves’ orbitopathy” and Presentation of a patient information DVD on this topic. Lecture for the Netherlands Society of Graves’ patients, November 2007

133. ‘Levator Resection for Congenital Blepharoptosis’. Third Rotterdam Oculoplastic Symposium, Rotterdam, November 22-24, 2007

134. ‘Levatordesinsertion in Graves Orbitopathy Patients’. 3rd Rotterdam Oculoplastic Symposium, Rotterdam, November 22-24, 2007

135. ‘Reconstruction of Large Eyelid Defects’. 3rd Rotterdam Oculoplastic Symposium, Rotterdam, November 22-24, 2007

136. ‘Correction of Lower Eyelid Retraction following Blepharoplasty’. 3rd Rotterdam Oculoplastic Symposium, Rotterdam, November 22-24, 2007

137. ‘Diplopia following Bony Decompression: Own Experience and a Meta-analysis of the Current Literature’. 1st Swiss Symposium on Thyroid Eye Disease, Pontresina, Switserland, Dec 5-7, 2007 (invited lecture)

138. ‘The Effect of Etanercept on TED: Results of a Pilot Study’. 1st Swiss Symposium on Thyroid Eye Disease, Pontresina, Switserland, Dec 5-7, 2007 (invited lecture)

 

2006

139. Paridaens D, Bosch WA vd, Paarlberg K. Upper lid reconstruction following lid-sparing subtotal full-thickness excision. 200th Annual Meeting of the Dutch Ophthalmic Society, 22-24 March 2006, Groningen, The Netherlands

140. Bosch WA vd, Leroux K, Paridaens D. Acquired capillary hemangioma in the lacrimal sac area. 200th Annual Meeting of the Dutch Ophthalmic Society, 22-24 March, Groningen, The Netherlands

141. Mensink H, van Doorn P, Weijtens O, Paridaens D. Graves’ orbitopathy in patients with neuromuscular disorders. 200th Annual Meeting of the Dutch Ophthalmic Society, 22-24 March 2006, Groningen, The Netherlands

142. Kesting S, Paridaens ADA. Ptosis as the first sign of orbital granular cell tumor. 200th Annual Meeting of the Dutch Ophthalmic Society, 22-24 March 2006, Groningen, The Netherlands

143. Lindstedt EW, Doornenbal P, Veckeneer M, Mooy CM, Paridaens ADA. Orbital inflammation as a presenting sign of intraocular malignant melanoma. 200th Annual Meeting of the Dutch Ophthalmic Society, 22-24 March, Groningen, The Netherlands

144. Paridaens D, vd Bosch WA. Orbicularis muscle flap vascularising free posterior and anterior lamellar graft : a one-stage ‘sandwich’ technique for eyelid reconstruction. A.R.V.O. Meeting, Ft Lauderdale, Fl, USA, April/May 2006

145. Paridaens D, vd Bosch WA. Orbicularis muscle flap vascularising free posterior and anterior lamellar graft : a one-stage ‘sandwich’ technique for eyelid reconstruction. Annual Meeting of ESOPRS, London, Sept 2006

146. “Complications of Ptosis Surgery”, “Current insights in the management of Graves’ Orbitopathy”, and “Shifting paradigms in the management of eyelid reconstruction”. 1st Zürich Oculoplastic Symposium, Zürich, March 4, 2006

147. “Correction of lower-lidretraction with the Medpor Lower Eyelid Spacer. 200th Annual Meeting of the Dutch Ophthalmic Society, Maastricht, March 24, 2006

148. “Blepharoplasty” COSMODERM VIII congress (of the European Society for Cosmetic and Aesthetic Dermatology (ESCAD)) in Rotterdam, June 9 (On invitation)

149. ‘Evisceration Techniques and the Post-Evisceration Socket Syndrome’ XVI Congreso de la Sociedad Espanola de Cirugia Plastica Ocular y Orbitaria, Barcelona June 15 (on invitation)

150. ‘Xanthogranulomatous Lesions of the Orbit’ XVI Congreso de la Sociedad Espanola de Cirugia Plastica Ocular y Orbitaria, Barcelona June 16 (on invitation)

 

2005

151. Donker DLT, Bosch WA vd, Paridaens D. Congenitale ptosis bij monozygote tweelingen, 199th Annual Meeting of the Dutch Ophthalmic Society, 16-18 March 2005, Maastricht, The Netherlands

152. Ugahary LC, Paridaens ADA. Stereotactische radiotherapie in de behandeling van opticus glioom. Idem

153. Jansen AFG, Mooy CM, Paridaens D. Corneaperforatie als gevolg van trachoom of……. Idem

154. Paridaens ADA, Bosch WA vd, Klijsen-Berkhout FLL. Entropion en ectropion na intra-oculaire chirurgie. Idem

155. “Behandeling van relatieve distale dacryostenose bij volwassenen: antegrade ballon catheter dilatatie met siliconenslangintubatie versus siliconenslangintubatie allleen”. 199th Annual Meeting of the Dutch Ophthalmic Society, Maastricht, March 18

156. “Orbitale implantaten: wat en hoe groot?” Lecture for Dutch Contact Group Patients with Eye Prosthesis (MMOP), Utrecht, April 16 2005

157. “Infections and Inflammatory Disorders of the Orbit”, LVAO lesdag Rotterdam, May 28, 2005

158. “Comparison of Balloon Dacryocystoplasty + Silicone Intubation with Silicone Intubation alone for the Treatment of Acquired Partial Nasolacrimal Duct Obstruction: a Prospective Randomized Trial. 23rd Annual Meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery, Crete, September 17, 2005

159. “Antegrade balloon dacryocystoplasty” Live lacrimal surgery symposium, Erasmus Medical Centre, Rotterdam, December 16, 2005

160. “Lower eyelid retraction: surgical options”, Rotterdam Eye Hospital, Rotterdam, December 20, 2005

 

2004

161. Bosch WA vd, Berkhout FLL, Klessen-Godfroy FJM, Loos vd THLJM, Paridaens ADA. De schildklierstatus van patienten met Graves’ophthalmopathie in het Oogziekenhuis Rotterdam, 198th Annual Meeting of the Dutch Ophthalmic Society, 2004, Amsterdam, The Netherlands

162. Donker DLT, Bosch WA vd, Tanghe HLJ, Paridaens ADA.

163. Periorbitale vasculaire afwijking of Graves’ ophthalmopathie?

164. Vegte vd S, Baarsma GS, Posthumus PJ, Paridaens ADA. Intra-oculaire metastase van een glans penis melanoom? Idem

165. Paridaens ADA, Broek vd PPh, Faber de JTHN, Kliffen M. Orbitaal leiomyoom. Idem

166. Homan MA, Sijssens KM, Paridaens ADA. Morbus Crohn of sarcoidose ?

167. Hiemstra CA, Paridaens ADA. Uveamelanoom na chronische immunosuppressie. Idem

168. Broek vd P, Bosch WA vd, Paridaens ADA. De relatie tussen implantdiameter en orbitaal volumetekort na enucleatie. Idem

169. Bosch WA vd, Paridaens ADA, Mooy CM. Ptosis en bovenlidzwelling bij patienten met siliconenolie in het oog. Idem

170. Baarsma GS, Sotodeh M, Keunen JEE, Paridaens ADA. Melanoma associated paraneoplastic syndromes. Idem

171. “De oogziekte van Graves: wat is het, wat doen we eraan en kunnen we het voorkomen?” Lecture for Thyroid Foundation, the Netherlands, Rotterdam, Februari 2004

172. “Gesteelde orbicularis oculi spierlap tussen vrije anterieure en posterieure lamel-transplantaten: een ‘’sandwich’’ techniek voor ooglid reconstructie. 198th Annual Meeting of the Dutch Ophthalmic Society, Amsterdam, March 24

173. “Complicaties van orbita decompressie”. Ot & Zien Congres for Orthoptists, Boymans van Beuningen Museum, Rotterdam, April 16

174. “Orbicularis oculi muscle flap in between of free anterior and posterior lamellar grafts: a sandwich technique for eyelid reconstruction. 22nd Meeting of ESOPRS, Leuven, Belgium, June 2004

 

2003

175. Lie AM, vd Bosch W, Grootendorst R, Paridaens ADA. De effectiviteit van transconjunctivale orbita decompressie in Graves’ophthalmopathie. 197th Annual Meeting of the Dutch Ophthalmic Society, Rotterdam, The Netherlands, April 9-11 2003

176. Hafezi F, Bockholts DA, Bosch vd WA, Paridaens ADA. Giant mucocele of all paranasal sinuses with massive bilateral globe displacement. Idem

177. Weijtens O, Paridaens ADA, vd Bosch WA. Totale bovenlidreconstructie met mucotarsale graft en vizierlap. Idem

178. Hiemstra CA, Paridaens ADA. Excisie van een perioculair angiosarcoom. Idem

179. Vd Vegte S, Kingma C, vd Bosch WA, Paridaens ADA, de Faber JTHN en Tjon Fo Sang M. Parry Romberg syndroom en orthoptische behandeling. Idem

180. “Beleid bij talgkliercarcinoom van het ooglid” 197th Annual Meeting of the Dutch Ophthalmic Society, Rotterdam, The Netherlands, April 9-11

181. “Orbital decompression for Graves’ orbitopathy: the OZR experience” and “Etanercept in Graves’orbitopathy: a pilot study”. Lectures for the Thyroid Foundation, the Netherlands Vlaardingen, April 2003

182. “Orbital implants: what and how?” Third Meeting of the Association of European Ocularists. Amsterdam, September 2003

183. “New concepts in eyelid reconstruction” International Course New Developments in Ophthalmology, Curacao, October, 2003

 

2002

184. van Ruyven RLJ, Eykenboom WMH, Mooy CM, van den Bosch WA, Paridaens ADA. Stereotactic Irradiation of Proven Primary Optic Nerve Sheath Meningeoma. Annual Meeting of the Dutch Ophthalmic Society, March 2002, Groningen, The Netherlands

185. Weytens O, Paridaens ADA, Wefers Bettink Remeijer M. Horner Syndrome in Wegener’s Disease. Idem

186. Paridaens D, Lie A, van den Bosch W, Mooy C. Caruncle tumor as first sign of metastatic lung carcinoma. Idem

187. Lohman AM, Paridaens ADA. Swelling underneath DCR scar due to nasal polyps. Idem

188. “Pilot study of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with moderate Graves’ ophthalmopathy”. Vancouver Orbital Symposium (Graves’ Orbitopathy and Orbital Disease). Vancouver, BC, Canada, March 15-17

189. “Pilot study of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with moderate Graves’ ophthalmopathy”. 196th Annual Meeting of the Dutch Ophthalmic Society, Groningen, The Netherlands, March 20-22

190. “First results of fractionated stereotactic radiotherapy of ocular melanomas”. Idem

191. “Current insights in eyelid reconstruction”. Idem

192. “Pilot study of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with moderate Graves’ ophthalmopathy”. 20th Annual Meeting of ESOPRS, Muenster, Germany, September 2002

193. “How to prevent complications in upper lid blepharoplasty”

194. Oculoplastic Symposium Rotterdam, November 2002. (Co-organiser)

195. “Entropion” Oculoplastic Symposium Rotterdam, November 2002. (Co-organiser)

196. “Silicone tube intubation and balloon catheterisation in distal lacrimal stenosis”. Oculoplastic Symposium Rotterdam, November 2002 (Co-organiser)

197. “Orbital decompression in 100 patients with Graves’ orbitopathy: the OZR experience” and “Etanercept in Graves’ orbitopathy: a pilot study”. Lectures for the Netherlands Society of Graves’ patients, November 2002

 

2001

198. Van Overdam KA, Paridaens ADA. An orbital gunshot-wound. Idem

199. Lohman A, Mooy N, Paridaens D. Adenocarcinoma ex pleiomorphic adenoma of the lacrimal gland. Annual Meeting of the Dutch Ophthalmic Society, March 2001, Maastricht, The Netherlands

200. Ruyven R, Bosch vd W, Hagen v M, Mooy N, Kwekkeboom D, Paridaens D. Optic nerve compression in Erdheim Chester’s disease. Idem

201. “Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis”. 195th Annual Meeting of the Dutch Ophthalmic Society, Maastricht, The Netherlands, March 2001

202. “Diagnostic dilemma’s in iris melanoma”. Xth International Congress of Ocular Oncology (ICOO), Amsterdam, The Netherlands, June 2001

203. “Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis”. 19th Annual Meeting of ESOPRS, Santiago de Compostela, Spain, June 2001

 

2000

204. Tabak S, Paridaens ADA, Mooy CM. Het apocriene zweetkliercarcinoom van het ooglid. Annual Meeting of the Dutch Ophthalmic Society, March 2000, Rotterdam, The Netherlands

205. Philips van LAM, Paridaens ADA. Abducens parese, een zeldzame complicatie van een lumbaal punctie. Idem

206. Ruyven van RLJ, Bosch vd WA, Mooy CM, Paridaens ADA. Ptosis als eerste teken van een gemetastaseerd huidmelanoom. Idem

207. Heule-Dieleman HAG, Bosch vd WA, Paridaens ADA. Orbital metastasis of breast carcinoma: a diagnostic challenge. Idem

208. Bosch vd WA, Paridaens ADA. Klinische presentatie en behandeling van canaliculitis. Idem

209. “Diplopie na ‘swinging eyelid’ decompressie bij Graves’ ophthalmopathie”. 194 th Annual Meeting of the Dutch Ophthalmic Society, Rotterdam, The Netherlands, March 2000

210. “Somatostatin Scintigraphy in Patients with Uveitis or Eye Tumors”. VI. International Symposium on Ocular Inflammation. Istanbul, Turkey, June 2000

211. “Recent developments in orbital decompression”. Symposium Meeting with the Dutch Thyroid Foundation, organised by the author. Rotterdam, June 2000

212. “Transconjunctival orbital decompression: lateral wall approach ab interno”. 18th Annual Meeting of the European Society of Ophthalmic Plastic & Reconstructive Surgery (ESOPRS), Paris, September 2000

213. Paridaens AD, Colen TP, Lemij HG, Mourits MPh, Bosch van den WA. Comparative artificial eye motility with acrylic and hydroxyapatite spherical enucleation implants. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Fl, USA. April 30- May 5 2000

214. Naus NC, Klein de A, Drunen van E, Paridaens DA, Luyten GP, Ksander B, Beverloo B, Slater RM. Characterisation of complex cytogenetic abnormalities in uveal melanoma using spectral karyotyping. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, Fl, USA. April 30- May 5 2000

 

1999

215. Naus NC, Mooy CM, Klein de A, Bosch vd WA, Paridaens DA. Chondrosarcoom van de orbita in een patient met Morbus Paget. Annual Meeting of the Dutch Ophthalmic Society, Amsterdam, March 1999

216. Bouwens M, Ruyven van R, Hoed den I, Paridaens ADA, Bosch vd WA. Frontalis suspensie bij congenitale ptosis: een vergelijking tussen suspensie materiaal. Annual Meeting of the Dutch Ophthalmic Society, Amsterdam, March 1999

217. Bouwens M, Paridaens ADA, Mourits MPh, Janssen G. Mesectodermaal leiomyoom van het corpus ciliare dat zich klinisch presenteerde als een melanoom. Idem

218. Wouters RJ, Bosch vd WA, Poublon RML, Paridaens ADA. Orbita decompressie bij Graves’ orbitopathie zonder proptosis reductie: hoe kan dat? Idem

219. Mooy CM, Born vd I, Kraaijenbrink Th, Bergen A, Baarsma S, Paridaens D. X-linked juveniele retinoschisis. Idem

220. “Minimal Incision” orbita decompressie bij Graves’ orbitopathie: een nieuwe benadering. 193 th Annual Meeting of the Dutch Ophthalmic Society, Amsterdam, The Netherlands, March 1999

221. “Minimal Incision” orbita decompressie bij Graves’ orbitopathie: een nieuwe benadering Scientific symposium 125th anniversary of the Rotterdam Eye Hospital, Rotterdam, September 1999

222. “Orbital decompression: new concepts”. Symposium Meeting of the Dutch Foundation of Graves patients (NVGP), Rotterdam, organised by author

223. “The versatility of the Hughesflap in eyelid reconstruction”. Eyelid & Orbit Symposium, Nijmegen, The Netherlands, December 1999

224. “Antegrade balloon cathetherisation in naso-lacrimal duct stenosis”, idem

225. “Silicone intubation in children”, idem

226. Paridaens ADA, Hans K, Buitenen van S, Mourits MPh. The Incidence of diplopia following coronal and inferomedial orbital decompression in Graves’ orbitopathy. VIth International Symposium on Graves’ Ophthalmopathy, Amsterdam, The Netherlands

 

1998

227. “Adult-onset orbital xanthogranulomas associated with lymphadenopathy and asthma”. 192 th Annual Meeting of the Dutch Ophthalmic Society, Maastricht, The Netherlands, March 1998

 

1997

228. De Faber JT, Grootendorst R, Paridaens D. Subconjunctival abscess as a complication of strabismus surgery. Transactions of the 24th Meeting of the European Strabismological Association, Portugal, 1997

229. “What causes a high skin crease in aponeurogenic ptosis? A new anatomical concept”. W.A. van den Bosch & A.D.A. Paridaens. 15th Annual Meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS), Rome, Italy, October 1997

230. “Schildklierziekten en oogafwijkingen”. Lecture for Schildklierlotgenoten DWO, Reinier de Graaf Gasthuis, Delft, The Netherlands, November 1997

 

1996

231. “The incidence of diplopia following coronal and inferomedial orbital decompression in Graves’ orbitopathy”. 14th Annual Meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS), Utrecht, The Netherlands, June 1996

232. “Incidentie van diplopie na coronale en inferomediale orbitadecompressie bij Graves’ orbitopathie”. 190th Annual Meeting of the Dutch Ophthalmic Society, Breda, The Netherlands, March 1996

 

1995

233. Paridaens D, Jansen G, Hardus P, Mourits MPh. Primary bilateral amyloidosis of the conjunctiva. Annual Meeting of the Dutch Ophthalmic Society, Groningen, March 1995

234. “Orbital exenteration in 95 cases of conjunctival malignant melanoma”. 13th Annual Meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS), Rostock, Germany, May 1995

 

1994

235. Paridaens ADA, Minassian DC, McCartney ACE, Hungerford JL. Prognostic factors in malignant melanoma of the conjunctiva: a clinico-pathological study of 256 cases (abstract). Key Ophthalmol, 1994

236. Paridaens ADA, Minassian DC, McCartney ACE, Hungerford JL. Prognostic factors in malignant melanoma of the conjunctiva: a clinico-pathological study of 256 cases (abstract). Year Book of Ophthalmology, Mosby & Co, Chicago, Illinois, 1994

237. “Orbital exenteration in the management of conjunctival malignant melanoma”. Meeting of the Dutch Ocular Oncology Committee (OOC), March 1994

238. “Orbital exenteration in 95 cases of conjunctival malignant melanoma”. 27th International Congress of Ophthalmology, Toronto, Canada, June 1994

239. “Prognostic factors in primary conjunctival malignant melanoma” 27th International Congress of Ophthalmology, Toronto, Canada, June 1994

240. “Clinico-pathological aspects of conjunctival melanoma”. Meeting of the Dutch Melanoma Society, November 1994

 

1993

241. Paridaens ADA, McCartney ACE, Curling OM, Lyons CJ, Hungerford JL. Impression cytology of conjunctival melanosis and melanoma (abstract). Year Book of Ophthalmology, Mosby & Co, Chicago, Illinois, 1993

242. “Prognostic factors in malignant melanoma of the conjunctiva”. 187th Annual Meeting of the Dutch Ophthalmic Society, Utrecht, The Netherlands, March 1993

 

1992

243. “Oestrogen receptors in conjunctival melanoma: a immuno-histochemical study”. 186th Annual Meeting of the Dutch Ophthalmic Society, Maastricht, The Netherlands, June 1992

 

1991

244. Paridaens ADA, Lyons CJ, Curling OM, Hungerford JL, McCartney ACE. Impression cytology in the management of conjunctival melanocytic lesions. 162nd Meeting of the Pathological Society of Great Britain and Ireland, Cambridge, January 1991 & William Harvey Day’s Academic Programme, St Bartholomew’s Hospital, London, Oct 1991

245. Paridaens ADA, Russell-Eggitt I, McCartney ACE. Congenital iris stromal cysts: pathological and immunological features. Annual Meeting of The Association for Research in Vision and Ophthalmology, Sarasota, Fl, USA, April 1991

246. “Oestrogen receptors and conjunctival malignant melanoma”. Oncology Meeting, Moorfields Eye Hospital, London, January 1991

247. “Proton irradiation of in vitro cultured ocular melanoma cells”. Idem, April 1991

248. “The effects of proton irradiation on ocular melanoma cells”. Clinical Science Meeting, Moorfields Eye Hospital, London, August, 1991

 

1990

249. “Familial iris melanoma”. F.R.C.S. course, Institute of Ophthalmology, London, September 1990

250. “Early disturbances in the visual system in Myotonic Dystrophy”. Annual Meeting of the Dutch Society of Neuro-ophthalmology, Erasmus University Rotterdam, Rotterdam, The Netherlands, November 1990

Summary (Nov 2014)

  • Original articles: 73
  • Case reports 34
  • Reviews 2
  • Editorials 7
  • Books/DVD 3
  • Chapters 7
  • Citation Report (March 2014)
  • Web of Knowledge [5.5}:
  • Results found: 107
  • Sum of the Times cited: 1003
  • Average Citations per Item: 9.37
  • h-index: 17

 

 

 

Leave a Reply